The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial

BACKGROUND: Each year, worldwide about 530,000 women die from causes related to pregnancy and childbirth. Of the deaths 99% are in low and middle income countries. Obstetric haemorrhage is the leading cause of maternal mortality, most occurring in the postpartum period. Systemic antifibrinolytic age...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Shakur, Haleema, Elbourne, Diana, Gülmezoglu, Metin, Alfirevic, Zarko, Ronsmans, Carine, Allen, Elizabeth, Roberts, Ian
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2010
Sujets:
Study protocol
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2864262/
https://ncbi.nlm.nih.gov/pubmed/20398351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-11-40
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires